Mvasi (Bevacizumab) Solution 400Mg/16Ml With 1 Skip to content
Local deliveries in La Paz, Los Cabos, Querétaro, and San Miguel de Allende. National shipping to all of Mexico.
Local deliveries in La Paz, Los Cabos, Querétaro, and San Miguel de Allende. National shipping throughout Mexico

Mvasi (Bevacizumab) Solution 400Mg/16Ml With 1

by Amgen
Save 10% Save 10%
Original price $ 40,000.00
Original price $ 40,000.00 - Original price $ 40,000.00
Original price $ 40,000.00
Current price $ 36,000.00
$ 36,000.00 - $ 36,000.00
Current price $ 36,000.00

La venta de este medicamento requiere receta médica. Su dispensación está sujeta a la validación de la receta y al cumplimiento de la normativa sanitaria vigente. La información contenida en este sitio tiene fines exclusivamente informativos y comerciales, incluyendo la descripción y el precio del producto, y no sustituye la valoración, diagnóstico o prescripción de un profesional de la salud.

SKU 8715131022631
Availability:
Only 1 left!
Notify me when they have inventory available

Category

Oncological

Line

Antineoplastic

Brand

Mvasi

Molecule

Bevacizumab

Presentation

400 mg/16 ml solution with 1 vial

Laboratory

Amgen

Indications

Mvasi (Bevacizumab) is indicated for the treatment of adult patients with metastatic colorectal cancer, in combination with chemotherapy. It is also used in the treatment of metastatic breast cancer, non-small cell lung cancer, kidney cancer, and glioblastoma multiforme. Its main function is to inhibit the formation of new blood vessels (angiogenesis) that feed tumor growth, which contributes to tumor size reduction and improved survival in patients with certain types of cancer.

Composition

Each Mvasi vial contains 400 mg of Bevacizumab in 16 ml of solution. Additionally, it contains excipients that ensure the stability and preservation of the product.

Contraindications

The use of Mvasi is contraindicated in patients with known hypersensitivity to Bevacizumab or any of the product's excipients. It is also contraindicated in patients with severe cardiovascular diseases, such as recent myocardial infarction, or in those with active bleeding or bleeding disorders. Its use is not recommended during pregnancy and breastfeeding.

Precautions

Precautions should be taken in patients with a history of thrombosis, uncontrolled hypertension, or diseases that may increase the risk of bleeding. It is important to monitor renal function, as the use of Bevacizumab may be associated with the occurrence of proteinuria and nephrotic syndrome. In addition, close monitoring of patients during and after treatment is recommended to detect possible adverse effects.

Storage

Store refrigerated between 2°C and 8°C. Do not freeze. Keep the vial in its original packaging to protect it from light. The medication must be used before the expiration date indicated on the package.

Prescription required.

Consult your doctor.

Shipping

  1. Free home delivery by local branches on orders over $1000. Otherwise, a $50 fee will be added in the cities of Querétaro and La Paz, BCS, and $150 in San José del Cabo and Cabo San Lucas, BCS.
  2. FREE national shipping via ground on orders over $1,500.00. Otherwise, a fee of $170.00 MXN (One hundred seventy Mexican pesos) will be added for a standard package with dimensions up to 20cm x 20cm x 20cm and 1kg in weight, and $290.00 MXN (Two hundred ninety Mexican pesos) for packages exceeding the aforementioned dimensions or weight.
  3. In case of oversized items, the corresponding fee will apply according to the parcel service.
  4. Orders received after 2:00 PM will be shipped the next day.
  5. For more details, please consult our shipping policy.

Payment and Security

Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.

Category

Oncological

Line

Antineoplastic

Brand

Mvasi

Molecule

Bevacizumab

Presentation

400 mg/16 ml solution with 1 vial

Laboratory

Amgen

Indications

Mvasi (Bevacizumab) is indicated for the treatment of adult patients with metastatic colorectal cancer, in combination with chemotherapy. It is also used in the treatment of metastatic breast cancer, non-small cell lung cancer, kidney cancer, and glioblastoma multiforme. Its main function is to inhibit the formation of new blood vessels (angiogenesis) that feed tumor growth, which contributes to tumor size reduction and improved survival in patients with certain types of cancer.

Composition

Each Mvasi vial contains 400 mg of Bevacizumab in 16 ml of solution. Additionally, it contains excipients that ensure the stability and preservation of the product.

Contraindications

The use of Mvasi is contraindicated in patients with known hypersensitivity to Bevacizumab or any of the product's excipients. It is also contraindicated in patients with severe cardiovascular diseases, such as recent myocardial infarction, or in those with active bleeding or bleeding disorders. Its use is not recommended during pregnancy and breastfeeding.

Precautions

Precautions should be taken in patients with a history of thrombosis, uncontrolled hypertension, or diseases that may increase the risk of bleeding. It is important to monitor renal function, as the use of Bevacizumab may be associated with the occurrence of proteinuria and nephrotic syndrome. In addition, close monitoring of patients during and after treatment is recommended to detect possible adverse effects.

Storage

Store refrigerated between 2°C and 8°C. Do not freeze. Keep the vial in its original packaging to protect it from light. The medication must be used before the expiration date indicated on the package.

Prescription required.

Consult your doctor.